Objective: To evaluate the early outcomes of transurethral resection of the prostate (TURP) for benign prostatic hyperplasia at 354 Military Hospital.
Subjects and Methods: A prospective, longitudinal descriptive study was conducted on 64 patients diagnosed with benign prostatic hyperplasia who underwent TURP at the Department of Urology, 354 Military Hospital, General Department of Logistics, from July 2025 to June 2026.
Results: The mean age was 71.8 ± 6.5 years, with the majority aged 60–79 years (87.5%). Acute urinary retention was the most common reason for admission (60.9%), and hypertension was the most frequent comorbidity (50.0%). The mean prostate volume was 76.1 ± 32.0 g, with 78.1% of cases ≥ 50 g. The mean operative time was 69.4 ± 18.2 minutes. The mean duration of urethral catheterization was 4.7 ± 2.3 days. All procedures were successfully completed, with good outcomes in 82.8% and moderate outcomes in 17.2%. At 1 month postoperatively, 96.9% of patients showed good or fair improvement in IPSS, and 98.4% reported good or fair improvement in quality of life.
Conclusion: Monopolar TURP demonstrated a high success rate and significant improvement in urinary symptoms and quality of life. The procedure is safe and effective for the treatment of benign prostatic hyperplasia.